JPRN-UMIN000014632
Completed
Phase 2
The phase II study of induction chemotherapy with cetuximab/S-1/low dose cisplatin for oral squamous cell carcinoma patients - Induction chemotherapy with cetuximab/S-1/low dose cisplatin for oral squamous cell carcinoma patients
The workshop of chemotherapy for oral cancer0 sites55 target enrollmentJuly 25, 2014
Conditionsoral squamous cell carcinoma
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- oral squamous cell carcinoma
- Sponsor
- The workshop of chemotherapy for oral cancer
- Enrollment
- 55
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)double cancer case 2\)severe systemic complications 3\)metastasis to CNS 4\)ischemic heart disease 5\)active gastrointestinal ulcer 6\)severe mental disorder 7\) women who are fertile or during pregnancy 8\) past illness of severe drug allergy 9\) attending doctor's decision as unsuitable patient for this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancerPancreatic cancerJPRN-UMIN000034410Keio University School of Medicine40
Active, not recruiting
Phase 1
Phase I/II study of Induction Chemotherapy with weekly RAD001, Carboplatine and Paclitaxel in Unresectable or Inoperable Locally Advanced Head and NeckSquamous Cell Carcinoma (HNSCC) - CAPRAnresectable or Inoperable locally advanced head and neck squamous cellcarcinoma without any prior chemotherapy or radiotherapyMedDRA version: 9.1Level: PTClassification code 10041823Term: Squamous cell carcinomaEUCTR2008-005702-39-FRGERCOR50
Completed
Phase 1
Phase I/II study of induction chemotherapy with docetaxel,cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.esophageal neoplasmJPRN-UMIN000003370ational Cancer Center Hospital East30
Unknown
Phase 2
A Phase II study of induction chemotherapy S-1 and CDDP in patients with FDG-PET positive N2 disease of non-small cell lung cancer.JPRN-C000000358Fukushima Medical University25
Active, not recruiting
Not Applicable
Phase I/II study on induction chemotherapy followed by chemoradiation with or without lapatinib, a dual EGFR/ErbB2 kinase inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinomaEUCTR2006-002667-33-BEEuropean Organisation for Research and Treatment of Cancer